AVDL
AVDL
NASDAQ · Pharmaceuticals

Avadel Pharmaceuticals

$21.64
+0.01 (+0.05%)
As of Nov 7, 1:40 AM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 6 38%
Hold 10 63%
Sell 0 0%
Price Target
Analyst Price Target +437.3% upside
Low Target $84.09
Average Target $116.27
High Target $133.85
Current Price $21.64
Current
$21.64
Target
$116.27
$84.09 $116.27 avg $133.85
Scenario Analysis
Bear Case
$84.09
288.6%
Low target
Base Case
$116.27
+437.3%
Avg target
Bull Case
$133.85
+518.5%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$23.57
-8.2% from high
52-Week Low
$18.68
+15.8% from low
50-Day SMA
$21.51
+0.6% vs SMA
200-Day SMA
$15.56
+39.1% vs SMA
RSI (14)
61.3
Neutral
Target vs 52W High
$116.27
+393.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%